|
Market Cap (4-Jun) $15,812,900 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.029 |
52w Low $0.010 |
P/E - |
EPS 0 |
NTI released this announcement to the ASX on 10 March 2022, 20:13. The announcement is not marked as price sensitive, and is 12 page(s) in length and 37.94kb in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.086% short sold according to ASIC data. It was ranked the 486th most shorted stock on the ASX. It remains ranked 538th as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| Notification regarding unquoted securities - NTI | 10 March 2022, 20:13 |
| Medicinal Cannabis Presentation | 10 March 2022, 8:58 |
| Proposed issue of securities - NTI | 3 March 2022, 18:21 |
| Appointment of Chief Executive Officer | 3 March 2022, 9:11 |
You must be logged in to post a reply.
Neurotech International 